
News|Articles|June 6, 2005
New product newswire
From GlaxoSmithKline, Research Triangle Park, N.C., (919) 483-2100, comes Boostrix (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed [Tdap]). The product is indicated as a booster vaccine to be given as a single dose to patients aged 10 to 18. This booster adds a pertussis component to the tetanus/diphtheria booster routinely administered to teens.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Diet and Insulin Management Technology Show Most Consistent Benefits for Type 1 Diabetes
2
Pharmacists Now Authorized to Independently Prescribe Buprenorphine
3
Pharmacists Remain Health Care Focal Point as Vaccine Recommendations Change
4
ACIP Vote Eliminates Universal Recommendation for Newborn Hepatitis B Vaccine
5



































































































































